+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Comparative pharmacokinetics of methylprednisolone mp and its prodrugs following intravenous doses of methylprednisolone sodium succinate mpss and methylprednisolone suleptanate mpsp in humans



Comparative pharmacokinetics of methylprednisolone mp and its prodrugs following intravenous doses of methylprednisolone sodium succinate mpss and methylprednisolone suleptanate mpsp in humans



Clinical Pharmacology & Therapeutics 43(2): 189




(PDF emailed within 1 workday: $29.90)

Accession: 027966923

Download citation: RISBibTeXText


Related references

Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers. Journal of Clinical Pharmacology 34(11): 1109-1115, 1994

Comparison of single and multiple dose pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone suleptanate. Clinical Pharmacology & Therapeutics 45(2): 148, 1989

Seventy-two hour comparison of methylprednisolone suleptanate and methylprednisolone sodium succinate in patients with acute asthma. British Journal of Clinical Practice 50(8): 440-445, 1996

Pharmacokinetics of methylprednisolone methylprednisolone sodium succinate and methylprednisolone acetate in dogs. Journal of Pharmaceutical Sciences 75(3): 251-255, 1986

Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass. PharmacoTherapy 10(1): 29-34, 1990

Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(5): 377-379, 1988

Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. Journal of Pharmaceutical and Biomedical Analysis 19(5): 785-792, 2000

Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. Journal of Pharmaceutical & Biomedical Analysis 19(5): 785-792, 1999

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: Dose-dependent pharmacokinetics in rats. International Journal of Pharmaceutics (Kidlington) 229(1-2): 173-182, 23 October, 2001

Pharmacokinetics of methylprednisolone succinate methylprednisolone and lidocaine in the normal dog and during hemorrhagic shock. Journal of Pharmaceutical Sciences 76(7): 528-534, 1987

Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone. Journal of Investigational Allergology and Clinical Immunology 19(4): 330-332, 2009

Effects of methylprednisolone suleptanate (U-6759OA) a new methylprednisolone analogue, on type I-IV allergic reactions and antibody formation. Pharmacometrics 46(3): 187-196, 1993

Effect of methylprednisolone and "pulse" therapy with methylprednisolone sodium succinate on autologous immune complex nephritis in rats. Journal of Pharmacobio-Dynamics 3(2): 117-122, 1980

Serum and urine methylprednisolone and methylprednisolone sodium succinate assay by a highly sensitive high performance liquid chromatography method. Clinical Chemistry 32(6): 1167, 1986

Studies on the pharmacokinetics of methylprednisolone suleptanate (U-67590A): (2) Blood levels and tissue distribution of radioactivity in rats after 21-day consecutive intravenous doses of tritiated or carbon-14 U-67590A. Pharmacometrics 45(6): 507-518, 1993